Request Demo
Last update 20 Mar 2025
13-valent pneumococcal conjugate vaccine(Lanzhou Institute of Biological Products Co. Ltd.)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine |
Synonyms 13价肺炎球菌多糖结合疫苗（兰州生物） |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Related
19
Clinical Trials associated with 13-valent pneumococcal conjugate vaccine(Lanzhou Institute of Biological Products Co. Ltd.)CTRI/2022/04/041856
A phase 4, open-label, single-arm, multicenter study todescribe the safety of 13-valent pneumococcal conjugate vaccine in adults 18 To 49 years of age in India
PACTR202008503507113
The Influence of Pneumococcal Conjugate Vaccine-13 on Nasal Colonisation in a Controlled Human Infection Model of Pneumococcal Carriage in Malawi v1.3 05 Jan 2022
JPRN-UMIN000038760
Study of the immunogenicity of 13-valent pneumococcal conjugate vaccine in high-risk patients who were outside recommended ages for routine vaccination - Study of the immunogenicity of PCV13 in high-risk patients
100 Clinical Results associated with 13-valent pneumococcal conjugate vaccine(Lanzhou Institute of Biological Products Co. Ltd.)
Login to view more data
100 Translational Medicine associated with 13-valent pneumococcal conjugate vaccine(Lanzhou Institute of Biological Products Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with 13-valent pneumococcal conjugate vaccine(Lanzhou Institute of Biological Products Co. Ltd.)
Login to view more data
100 Deals associated with 13-valent pneumococcal conjugate vaccine(Lanzhou Institute of Biological Products Co. Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pneumococcal Infections | NDA/BLA | China | 16 Mar 2023 | |
| Pneumonia | Phase 2 | China | 21 Sep 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free